The Global Blood Gas and Electrolyte Analyser Market size is estimated to be USD 3.57 Billion in 2019 and is predicted to reach USD 6.24 Billion by 2030 with a CAGR of 5.2% from 2020-2030.
The blood gas and electrolyte analysers are used to measure blood gas and some metabolites in whole blood specimens. The analysers are also used to determine the abnormal electrolyte levels in the blood, levels of oxygen/carbon dioxide exchange, and the patient’s acid-base balance. Moreover, blood gas analysers are utilized to test several other parameters including O2 concentration, hydrogen ion and others in cases such as diabetes, blood vessel haemorrhage, drug overdose and shock.
Access Full Description of this report at:-
Top Companies: Radiometer Medical Aps (A Subsidiary of Danaher Corporation), Instrumentation Laboratory (A Werfen Company), Siemens AG, Roche Diagnostics Limited, Abbott Laboratories, Inc., Nova Biomedical, OPTI Medical Systems, Inc. (A Subsidiary of Idexx Laboratories, Inc.), ERBA Diagnostics Mannheim GmbH, Medica Corporation and Alere, Inc. and others.
There have been various developments taking place in the market that further enhance the blood gas and electrolyte analyser market growth at a large scale. For instance, in March 2020, U.S.FDA approved critical care testing solution, the RAPID Point 500e blood gas analyser by Siemens Healthineers, one of the leading med-tech companies. Moreover, In May 2020, Rochehad announced the CE mark availability of Roche v-TAC, a new digital diagnostic solution that allows clinicians to obtain results for arterial blood gas values from patients with respiratory or metabolic abnormalities via a simpler, less invasive venous puncture through the use of a digital algorithm.
Request sample copy of this report at:-
Geographic breakdown and analysis of each of the previously mentioned segments include regions comprising North America, Europe, Asia-Pacific, and RoW. North America represents higher adoption of blood gas and electrolyte analyzer market because of its advanced healthcare industry and increasing number of patient’s treatment in the ICUs, NICUs, and emergency wards. The market of Asia-Pacific is estimated to hold the maximum share due to rising investment by the government in healthcare infrastructure and the upsurge in number of patients suffering from chronic diseases.
About Next Move Strategy Consulting:
Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.
We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.
For more insights, please visit, https://www.nextmsc.com